PD-L1 expression implies the presence of spontaneous T cell recognition, followed by the activation and production of IFN-γ on-site, which provides predictive values for the responses of patients with melanoma, non–small cell lung cancer, and bladder cancers to ICI monotherapy (28). This evidence concerns the gene IFNG and urinary bladder carcinoma.